The temporary continuing resolution (CR) keeping the government funded at fiscal year (FY) 2024 levels will expire on December 20. It is imperative that Congress pass a funding bill for FY 2025 that provides robust investments for the National Institutes of Health (NIH), National Cancer Institute (NCI), and Advanced Research Projects Agency for Health (ARPA-H). Another CR providing temporary flat funding, or a government shutdown, could delay advances in cancer research and impact our patients’ access to innovative therapies.
It’s time to act! Urge your lawmakers to pass an FY 2025 funding bill that supports cancer research at the NIH, NCI, and ARPA-H by the end of the year